The Impact of Using Different Spinal Needle Sizes on the Efficacy of the Dural Puncture Epidural Block
NCT ID: NCT06287047
Last Updated: 2025-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2021-01-01
2024-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Intravascular Injection Between Blunt and Sharp Needles During Cervical Transforaminal Epidural Block.
NCT03286946
Perineural Catheter Insertion Distance for Continuous Peripheral Nerve Blocks
NCT00997867
A Comparison of Intravascular Injection With Chiba Needle and Whitacre Needle
NCT04204720
Cervical Epidural and Stellate Ganglion Block in Upper Limb Complex Regional Pain Syndrome
NCT05970146
Analgesic Efficacy of Intermediate Cervical Plexus Block in Patients Undergoing Neck Surgeries: A Comparison Between Two Bupivacaine Concentrations
NCT06621836
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* uncomplicated pregnancy
* Cephalic presentation
* Cervical dilatation \<5 cm
Exclusion criteria:
* Allergy to local anesthetics.
* Bleeding disorders
* Low platelet count
* Local or systemic sepsis
* Prior surgery in lumbosacral spine
* Patient's refusal.
Eighty-one patients meeting the inclusion criteria were randomly divided into three equal groups:
Group CE (n=27): Conventional epidural. Group DPE-25 (n=27): Dural puncture epidural with 25-gauge spinal needle. Group DPE-27 (n=27): Dural puncture epidural with 27-gauge spinal needle.
Randomization was done by computer generated numbers and concealed by serially numbered, opaque and sealed envelopes. The details of the series were unknown to the investigators and the group assignment was kept in a set of sealed envelopes, each bearing only the case number on the outside.
Full medical and surgical history were taken. Laboratory investigations were revised. Visual analogue scale was educated to the patient before the start of the operation.
One liter of lactated Ringer's solution was infused IV over 15 min during the neuraxial procedure.
The procedure was performed in the seated position. Parturients with VAS \< 5 were excluded.
The procedure was performed by a senior anesthesia resident.
Before administering medications through the epidural catheter, subarachnoid, intravascular and subdural placement had to be ruled out.
After 5 min of the first initial bolus dose, adequacy of analgesia was assessed.
Analgesia was considered adequate if VAS score is ≤3. Onset of analgesia was defined as from time of first bolus dose to time of achieving VAS ≤3.
Patient with VAS score \>3; considered failed block and were excluded from the study.
Analgesia was evaluated by a blinded observer assessing visual analog scale (VAS) pain scores, onset of analgesia, sensory level, and motor blockade.
The primary outcome was the onset of analgesia (defined as duration from injection of the first initial epidural bolus to attainment of VAS \<3).
Other data collected are:
1. Patients' demographic data.
2. Obstetrics data.
3. Onset of analgesia (attainment of VAS \<3).
4. HR and MABP (baseline, every 5 minutes until 15 mins, a every 15 mins till 1 hour and then every 1 hour till delivery).
5. Visual analogue scale (VAS) with hemodynamics.
6. Assessment of sensory level after 30 mins of the block.
7. Assessment of Sacral block during the 1st 30 minutes.
8. Assessment of motor block through the modified bromage scale
9. Occurrence of side effects as: Hypotension, bradycardia, nausea, vomiting and pruritis ,PDPH, nerve injury.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional epidural group
Conventional epidural.
.
Epidural analgesia
Epidural analgesia alone or with dural puncture with different sizes of spinal needles
DPE-25G group
Dural puncture epidural with 25-gauge spinal needle.
Epidural analgesia
Epidural analgesia alone or with dural puncture with different sizes of spinal needles
DPE-27G group
Dural puncture epidural with 27-gauge spinal needle.
Epidural analgesia
Epidural analgesia alone or with dural puncture with different sizes of spinal needles
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epidural analgesia
Epidural analgesia alone or with dural puncture with different sizes of spinal needles
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Uncomplicated pregnancy with vertex presentation
* Willing to participate in the study.
Exclusion Criteria
* Coagulopathy (INR\> 1.5 and platelets \< 80,000)
* Allergy to local anesthetics.
* Prior surgery in lumbosacral spine.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reham Mahrous
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medidcne, Cairo Univerisity
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
spinal needle sizes and DPE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.